| Literature DB >> 35757252 |
Kia Nøhr Iversen1, Karin Jonsson1, Rikard Landberg1.
Abstract
Consumption of whole grain has been associated with lower incidence of type-2 diabetes, cardiovascular disease and their risk factors including improved glycemic control. In comparison with other whole grain products, rye bread has been shown to induce lower insulin response in the postprandial phase, without affecting the glucose response. This phenomenon has been referred to as the "rye factor" and is being explored in this review where we summarize the findings from meal and extended meal studies including rye-based foods. Overall, results from intervention studies showed that rye-based foods vs. (wheat) control foods had positive effect on both insulin and glucose responses in the postprandial phase, rather than on insulin alone. Mechanistic studies have shown that the rye factor phenomenon might be due to slowing of the glucose uptake in the intestine. However, this has also been shown for wheat-based bread and is likely an effect of structural properties of the investigated foods rather than the rye per se. More carefully controlled studies where standardized structural properties of different cereals are linked to the postprandial response are needed to further elucidate the underlying mechanisms and determinants for the effect of specific cereals and product traits on postprandial glycemic control.Entities:
Keywords: cereals; diabetes; glucose; insulin; rye; rye factor; structure
Year: 2022 PMID: 35757252 PMCID: PMC9218669 DOI: 10.3389/fnut.2022.868938
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Pairs of rye-control comparisons extracted from the studies presented in Supplementary Table 1, grouped according to effect on postprandial insulin and glucose.
| Glucose ↓ | Glucose ↔ | Glucose ↓ | Glucose ↔ | Glucose or | |
|
| |||||
| Product type | Soft bread: 16 | Soft bread: 19 | Soft bread: 4 | Soft bread: 17 | Soft bread: 2 |
| Method of fermentation | Yeast: 14 | Yeast: 6 | Yeast: 1 | Yeast: 16 | Yeast: 2 |
| Cereal form | Bran: 0 | Bran: 0 | Bran: 0 | Bran: 3 | Bran: 1 |
| Rye content | 81.7 ± 9.7 | 96.4 ± 10.3 | 82.0 ± 15.7 | 82.3 ± 24.5 | 67.5 ± 46.0 |
|
| |||||
| Product type | Soft bread: 16 | Soft bread: 19 | Soft bread: 5 | Soft bread: 17 | Soft bread: 2 |
| Method of fermentation | Yeast: 16 | Yeast: 12 | Yeast: 1 | Yeast: 16 | Yeast: 0 |
| Cereal form | Kernels: 2 | Kernels: 1 | Kernels: 0 | Kernels: 5 | Kernels: 1 |
| Cereal source | 16 wheat, | 21 wheat, | 5 wheat | 18 wheat, | 2 wheat, |
|
| |||||
| Same product type within pair [ | 14 (78%) | 23 (100%) | 4 (80%) | 19 (83%) | 1 (33%) |
| Same cereal form within pair [ | 6 (33%) | 8 (35%) | 2 (40%) | 4 (17%) | 1 (33%) |
| Same method of fermentation | 12 of 13 (92%) | 5 of 13 (39%) | 1 of 1 (100%) | 13 of 16 (81%) | 0 of 1 (0%) |
|
|
| ||||
| 16/1/1 | 16/6/1 | 3/0/2 | 22/3/1 | 3/0/0 | |
FIGURE 1Total dietary fiber and available dietary fiber content of rye products and control products, categorized according to effect on postprandial glucose and insulin (Table 1). Data is mean and standard deviation.
Second meal effect studies.
| Design | Subjects | Intervention products | Study procedure | Outcomes (data analysis) | Results | |
| Sandberg et al. ( | Cross-over, randomized, two test meals | 38 (30 f/8 m), age 63.9 ± 5.5 year, BMI 24.2 ± 2.5 kg/m2, fasting glucose 5.7 ± 0.4 mmol/l, no known metabolic disease, non-smoking. | Rye bread with added resistant starch (RBRS):43% rye kernels, 43% whole grain rye flour 14% Hi-Maze flour (60% resistant starch type 2, 40% digestible starch). | Subjects consumed one portion of test bread per day for three days before visiting the clinic. On day 1 and 2 bread was divided over the day, on day 3 the portion was consumed at 9 pm. | Glucose (capillary blood), insulin (venous blood). | |
| Sandberg et al. ( | Cross-over, randomized, three test meals | 21 (10 m/11 f), age 25.3 ± 3.9 year, BMI 22.7 ± 2.3 kg/m2, no known metabolic disease, non-smoking. | Whole grain rye flour bread (RFB): 100% whole grain rye flour. | Subjects consumed test breads at 9 pm the night before visiting the clinic. | Glucose (all timepoints), insulin (all timepoints except 15 min) | No difference |
| Sandberg et al. ( | Cross-over, randomized, four test meals (2 × 2 factorial design) | 19 (9 m/10 f), age 21.9 ± 1.87 year, BMI 25.6 ± 3.5 kg/m2, no known metabolic disorders, non-smoking. | White wheat bread (WWB; reference): 85% rye kernels and 15% white wheat flour (of cereal dry matter). 121.4 g bread/portion. | Subjects consumed one portion of test bread with water at 9:30 pm either: the day before visiting the clinic (WWB-1D or RKB-1D) of for three consecutive days before visiting the clinic (WWB-3D or RKB-3D). At the clinical visit the subjects consumed 121.4 g WWB with 2 dl water after an overnight fast (from 9:30 pm). | Glucose (all timepoints), insulin (all timepoints except 15 min) | No effect of length of priming (1 or 3 days) were found in any of the outcomes. |
Studies investigating the effect on habitual consumption of rye products on glycemic control.
| Design | Subjects | Intervention products | Study procedure/clinical examinations | Outcomes (data analysis) | Results | |
| Eriksen et al. ( | Cross-over, randomized, two intervention period (8 + 8 weeks, separated by 8-week wash-out). | 49 men, age 49–74, BMI 26–41 kg/m2, signs of metabolic syndrome. | Rye period: breakfast cereals, crisp bread and pasta based on whole grain rye. | OGTT (75 g) in the beginning, middle and end of each intervention period (week 0, 4, and 8). Intravenous blood was drawn at 0, 30, 60, and 120 min. | Glucose, insulin. | No effect. |
| Lappi et al. ( | Cross-over, randomized, 4 weeks run-in period and two intervention periods (4 + 4 weeks). No wash out period. | 21 males and females, age 38–65 year, BMI 19–30 kg/m2, fasting glucose 4.9–6.3 mmol/l. | Refined wheat bread (WW; run-in period): two commercial breads with 100% white wheat flour, 20–35 g/slice. | 3-h meal test at the end of run-in period and end of each intervention period. | Glucose, insulin | |
| Laaksonen et al. ( | Parallel, 4-week run-in (habitual diet), hereafter randomized to one of two 12-week intervention arms. | 72 (36 m/36 f), metabolic syndrome, age 40–70 year, BMI 26–40 kg/m2. 65% had impaired fasting glucose, 42% had impaired glucose tolerance. | Oat-wheat-potato (OWP) group: wheat bran bread, graham crisp, graham toast and oat bread (60% whole meal oat). | OGTT at baseline and after 12 weeks. Glucose solution (75 g glucose) consumed after an overnight fast. | Glucose, insulin | IGI and DI increased more in the RP group, than in the OWP group (approx. 30% vs. 5%, |
| McIntosh et al. ( | Cross-over, randomized, three intervention periods (4 + 4 + 4 weeks). | 28 males, age 40–65 year, no gastrointestinal disorders, BMI 30 ± 0.9 kg/m2. | 1-h meal tolerance test at the end of each 4-week period. | Glucose, insulin. | ||
| Juntunen et al. ( | Cross-over, randomized, two intervention periods (8 + 8 weeks). Intervention was preceded by 2-3-week run-in period and separated by an 8-week wash-out period (both habitual diet). | 20 postmenopausal women, healthy, age 59 ± 6.0 year, BMI 27.5 ± 2.9 kg/m2. | Subjects were instructed to replace habitual bread with intervention breads during the 8-week intervention periods. Subjects were instructed to consume at least 4–5 portions of bread per day (20–28 g/174–249 kcal per portion). | Frequently sampled intravenous glucose tolerance test (FSIGTT) was conducted at baseline and after each intervention period. | Glucose, insulin. | The increase in AIR (compared to baseline) was higher in the rye period (9.9 ± 24.2%) than in the wheat period (2.8 ± 36.3%). |